A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects

NCT02663089 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: [14C]-GSK961081 solution for IV infusion
DRUG: [14C]-GSK961081 oral solution
DRUG: GSK961081 dry powder for inhalation

Sponsor

Theravance Biopharma

Collaborators

[object Object]
[object Object]